BowLeven Plc
21 October 2005
21 October 2005
BowLeven Plc ('BowLeven' or 'the Company')
Appointment of directors
The Company yesterday announced in its Preliminary Results announcement, the
appointment to the Board of BowLeven, of Robert Walvis, Steve Lowden and John
Morrow. None of the Directors appointed has a current interest in the share
capital of BowLeven, although it is the intention to grant certain Directors
options over ordinary shares in the near future following their appointments.
Commenting on the appointments Terry Heneaghan, Executive Chairman of BowLeven,
said: 'We are delighted to have been able to attract directors of the calibre of
Robert, Steve and John to the BowLeven Board. Their range of skills will
complement and enhance the Board of BowLeven and will help enormously to guide
the Company forward as it seeks to develop its assets.'
For further information please contact:
Terry Heneaghan, Executive Chairman BowLeven Plc 0131 260 5100
Adam Westcott, Noble & Company Limited 0131 225 9677
Neil Bennett, Maitland 020 7379 5151
Additional information
Robert Walvis
In accordance with Schedule 2 (g) of the AIM Rules, the following information in
relation to the appointment of Robert Joris Willem Walvis (age 58) as a director
of BowLeven is disclosed:
Current directorships and partnerships:
Balfour Beatty Plc, Non-Executive Director
Johnson Matthey Plc, Non-Executive Director
Allianz Nederland, Chairman
Directorships and partnerships held in the past five years:
Shell International Limited, Director
The Netherlands British Chamber of Commerce, Director
The Royal Institute of International Affairs, Director
Save for the information disclosed above there is no other information falling
to be disclosed under Schedule 2(g) of the AIM Rules.
John Morrow
In accordance with Schedule 2 (g) of the AIM Rules, the following information in
relation to the appointment of John Andrew Corran Morrow (age 51) as a director
of BowLeven is disclosed:
Current directorships and partnerships:
None
Directorships and partnerships held in the past five years:
BG Karachaganak Limited, Vice President
Save for the information disclosed above there is no other information falling
to be disclosed under Schedule 2(g) of the AIM Rules.
Steven Lowden
In accordance with Schedule 2 (g) of the AIM Rules, the following information in
relation to the appointment of Steven Lowden (age 47) as a director of BowLeven
is disclosed:
Current directorships and partnerships:
None
Directorships and partnerships held in the past five years:
Marathon International Petroleum, Ltd, Officer and Senior Vice President
Business D
Chairman of EGLNGCo.
Save for the information disclosed above there is no other information falling
to be disclosed under Schedule 2(g) of the AIM Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.